To enable precision oncology in patients with solid tumors, we developed Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT), a hybridization capture-based next-generation sequencing assay for targeted deep sequencing of all exons and selected introns of 341 ...
MSK-IMPACT: A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology. Hameed M, Nafa K, Arcila ME, Berger MF: Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): a hybridization capture-based next-generation...
Alicia Latham, Maria I. Carlo, Karen Cadoo, Semanti Murkherjee, Emily K. Slotkin, Tanya Trippett, Julia Glade Bender, Paul A. Meyers, Leonard Wexler, Filemon S. Dela Cruz, Nai-Kong Cheung, Ellen Basu, Alex Kentsis, Ahmet Zehir& ...